Patients’ risk of pathologic upgrading may depend on their intermediate-risk factor (Gleason score 3+4, PSA level of 10-20 ng/mL, and cT2b-c disease).
The…
[mc4wp_form id="449"]
A team of researchers sought to evaluate the association between the Genomic Prostate Score and long-term outcomes in patients having undergone radical…
Robotic-assisted radical prostatectomy is associated with higher costs than open radical prostatectomy at the index hospitalization for the surgery, but it is…
Overall, Black and White men with metastatic castration-resistant prostate cancer had similar median overall survival times, according to a British study.
The post…
A retrospective study found that a radiomic-clinicopathologic nomogram performed better than other tools in predicting biochemical recurrence-free survival after surgery for prostate…
In a small phase 2 trial involving men with intermediate-risk prostate cancer, a single ultra-high dose of radiation was safe and comparable…
The goal of the TRANSFORMER study was to compare the effects of bipolar androgen therapy with enzalutamide in asymptomatic men with castration-resistant…
In a propensity score-based study, prostate cryoablation added to androgen deprivation therapy (ADT) improved failure-free survival and survival without castration-resistant disease compared…
Use of 5-alpha-reductase inhibitors (5-ARIs) by men on active surveillance (AS) for prostate cancer is associated with a lower likelihood of definitive treatment and pathologic progression, according to…
Salvage radical prostatectomy (SRP) complication rates and functional outcomes are better after primary focal therapy (FT) than after primary radiation therapy (RT) for prostate cancer, investigators reported in…